ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0126

Mechanosensory Channel Localization in Ultrasonography Targets Organs Involved in AKI Protection

Session Information

  • AKI: Mechanisms - 1
    November 06, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Yao, Junlan, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, Virginia, United States
  • Zheng, Shuqiu, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, Virginia, United States
  • Sung, Sun-sang J., Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, Virginia, United States
  • Okusa, Mark D., Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia, Charlottesville, Virginia, United States
Background

Ultrasound treatment of mouse kidneys or spleen protects mice from acute kidney injury (AKI) in renal ischemia-reperfusion injury (IRI) and lipopolysaccharide (LPS)-induced injury models. Using mutant mice with cell-type specific deletion of mechanosensory channels (MSC) in AKI models, we sought to determine whether Piezo1, Piezo2, and TrpV4 were key molecules that conferred ultrasound protection. To fully understand the mechanism of renal AKI protection by ultrasound, we studied the cellular distribution of these 3 MSCs in kidney and spleen.

Methods

C57BL/6J mice undergoing AKI by IRI or LPS were treated with ultrasound and compared with appropriate controls. Serum creatinine, kidney histology, and mRNA expression of inflammatory genes were monitored at the end of experiments. Confocal microscopy of MSCs with cell-type specific markers were used for tissue distribution studies.

Results

In the spleen, Piezo1 was expressed by macrophages in the red pulp and in the periarterial T cell zone. Piezo2 on the other hand was expressed by neuronal cells positive for tyrosine hydroxylase and neurofilament heavy chain. Some Piezo2+ nerve endings were found to be juxtaposed against the macrophage membrane. TrpV4 was expressed by F4/80+ macrophages and CD31+ endothelial cells. In the kidney, besides the expression of MSCs on cell types common between kidney and spleen, abundant MSCs were expressed on tubular epithelial cells. Piezo1 was expressed in descending thin limbs marked by Bst1, thick ascending limbs marked by THP, and connecting tubules and collecting ducts identified by Epcam and Claudin 7. In addition to its expression in distal tubules, TrpV4 was expressed by proximal tubules. Because ultrasound protection of LPS-induced AKI may be mediated by the activation of Nrf2 by Piezo1, the localization of Nrf2 in kidney was examined. The primary Nrf2 expressing kidney segment was the Bst1+ thin descending limb. These studies showed that kidney tubules may provide AKI protection by responding to ultrasound treatment through MSCs.

Conclusion

The AKI protection of ultrasound may involve the complex interaction of MSC responses of multiple cell types including hematopoietic cells, neuronal cells, endothelial cells, and kidney tubular epithelial cells in spleen and kidney.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)